SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis

Area of Science:

• Endocrinology
• Molecular Biology
• Skeletal Biology

Background:

• Suppressor of Cytokine Signaling-2 (SOCS2) negatively regulates growth hormone (GH) signaling and bone growth via the JAK/STAT pathway.
• SOCS2 knockout mice exhibit an overgrowth phenotype with normal systemic IGF-1 levels.
• The local effects of GH on bone growth require further elucidation.

Purpose of the Study:

• To investigate the role of SOCS2 in mediating the local actions of GH on epiphyseal chondrocytes and bone growth.
• To understand the SOCS2 signaling mechanisms involved in GH-induced bone growth.

Main Methods:

• GH challenge on cultured chondrocytes to assess SOCS2 expression.
• Gain- and loss-of-function studies in chondrocytes to evaluate STAT phosphorylation.
• Analysis of embryonic metatarsal growth and chondrocyte proliferation in SOCS2 knockout models.
• Assessment of bone growth rates, growth plate width, and chondrocyte proliferation in 6-week-old SOCS2 knockout mice.

Main Results:

• SOCS2 expression increased in chondrocytes following GH challenge.
• GH-stimulated STAT phosphorylation (STATs-1, -3, and -5) was elevated in SOCS2-deficient chondrocytes.
• SOCS2 deficiency led to increased longitudinal growth of embryonic metatarsals and enhanced chondrocyte proliferation.
• SOCS2 knockout mice showed increased bone growth rates, growth plate widths, and proliferation of hypertrophic chondrocytes.

Conclusions:

• SOCS2 acts as a negative regulator of local GH signaling in chondrocytes.
• The absence of SOCS2 enhances GH-induced STAT signaling, leading to increased chondrocyte proliferation and bone growth.
• The SOCS2 knockout mouse is a suitable model for studying the local effects of GH on bone growth.